Journal of the Advanced Practitioner in Oncology

Journal of the Advanced Practitioner in Oncology We are the first peer-reviewed journal developed for advanced practitioners in oncology.

The Journal of the Advanced Practitioner in Oncology (JADPRO) is a peer-reviewed publication published 8 times a year.

Advanced practitioners, share your work with your peers by submitting an abstract to ! Present innovative, original wor...
06/12/2026

Advanced practitioners, share your work with your peers by submitting an abstract to ! Present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology. The deadline to submit is July 1.
Learn more about the poster tracks and access full guidelines: https://bit.ly/3OFOlbQ

Managing Eye-Related Adverse Events Caused by Cancer Treatments Learn more: https://go.conexiant.com/Eye-RelatedIntended...
06/11/2026

Managing Eye-Related Adverse Events Caused by Cancer Treatments

Learn more: https://go.conexiant.com/Eye-Related

Intended for US Healthcare Professionals.
©2025 AstraZeneca. All rights reserved.
US-107229 Last Updated 12/25

As oncology care becomes increasingly complex, collaboration between advanced practice providers and medical science lia...
06/09/2026

As oncology care becomes increasingly complex, collaboration between advanced practice providers and medical science liaisons is more important than ever.

This article explores how APP-MSL partnerships support clinical research, medical education, and scientific exchange, helping bridge the gap between innovation and real-world patient care.

Learn more: https://jadpro.com/online-first/2026/building-bridges-the-impact-of-medical-science-liaison-and-advanced-practice-provider-collaborations/

🩸 Immune checkpoint inhibitors are reshaping frontline treatment strategies in Hodgkin lymphoma.This article explores th...
06/05/2026

🩸 Immune checkpoint inhibitors are reshaping frontline treatment strategies in Hodgkin lymphoma.
This article explores the growing role of nivolumab-AVD in advanced-stage HL and provides evidence-based guidance for managing the toxicities associated with this evolving regimen.

Topics include:
• Immune-mediated adverse events
• Monitoring and management strategies
• Practical clinical considerations for oncology APPs
• A real-world patient case study

Read the article: https://jadpro.com/online-first/2026/advances-in-hodgkin-lymphoma-treatment-clinical-considerations-for-managing-toxicities-in-nivolumab-avd-therapy/

🎉 Registration is OPEN for JADPRO Live! Don’t miss the year’s most anticipated educational conference for oncology APs. ...
06/04/2026

🎉 Registration is OPEN for JADPRO Live!

Don’t miss the year’s most anticipated educational conference for oncology APs.

Join advanced practitioners from across the country to learn about the latest innovations in oncology from October 15–18 in Minneapolis.

Secure Your Spot: https://jadprolive.com/registration/

05/21/2026

Advanced practitioners are shaping the future of oncology care and JADPRO Live is where that work takes center stage.

Amber Koehler, MPAS, PA-C, of Mayo Clinic and this year’s Conference Chair, shares why JADPRO Live is the premier meeting for oncology APs: a place to learn, collaborate, and support one another while advancing patient care.

Join the community where APs are at the heart of cancer care.
JADPRO Live 2026 | Minneapolis | Oct. 15–18
Register: https://bit.ly/42DNFaH

🚨 Last call to register! Managing relapsed AML in the era of targeted therapy presents new challenges and opportunities....
05/20/2026

🚨 Last call to register! Managing relapsed AML in the era of targeted therapy presents new challenges and opportunities.

Join this live webinar with Karolina Faysman, MSN, AOCNP, DNP(c), of UCLA Health’s Department of Hematological Malignancies and Cellular Therapies, as she explores case-based strategies for monitoring and managing patients on menin inhibitors, with a focus on NPM1-mutated AML.

📅 May 20 | 6–7 PM EDT
💡Designed for advanced practitioners

Register today to reserve your spot: https://jadpro.broadcastmed.io/live/75/page/523

Frailty assessment is becoming increasingly important in frontline treatment planning for transplant-ineligible multiple...
05/20/2026

Frailty assessment is becoming increasingly important in frontline treatment planning for transplant-ineligible multiple myeloma.
Emerging data suggest that carefully selected patients may benefit from quadruplet therapy, reinforcing the need for personalized approaches that balance efficacy, tolerability, and quality of life.
Learn more: https://bit.ly/4dg7BFh

Address

94 N Woodhull Road
Huntington, NY
11743

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Journal of the Advanced Practitioner in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Journal of the Advanced Practitioner in Oncology:

Shortcuts

Share

Category